Lpl Financial LLC Biogen Inc. Transaction History

Lpl Financial LLC

  • $196 Billion
  • Q2 2024

A detailed history of Lpl Financial LLC transactions in Biogen Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 51,498 shares of BIIB stock, worth $8.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
51,498
Previous 48,165 6.92%
Holding current value
$8.95 Million
Previous $10.4 Million 14.95%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$190.52 - $236.72 $635,003 - $788,987
3,333 Added 6.92%
51,498 $11.9 Million
Q1 2024

May 10, 2024
BUY
$212.02 - $267.71 $656,201 - $828,562
3,095 Added 6.87%
48,165 $10.4 Million
Q4 2023

Feb 14, 2024
SELL
$222.59 - $267.94 $1.28 Million - $1.54 Million
-5,740 Reduced 11.3%
45,070 $11.7 Million
Q3 2023

Nov 13, 2023
BUY
$253.3 - $285.89 $2.22 Million - $2.51 Million
8,781 Added 20.89%
50,810 $13.1 Million
Q2 2023

Jul 31, 2023
SELL
$275.25 - $318.06 $137,625 - $159,030
-500 Reduced 1.18%
42,029 $12 Million
Q1 2023

May 10, 2023
SELL
$256.56 - $292.34 $5,644 - $6,431
-22 Reduced 0.05%
42,529 $11.8 Million
Q4 2022

Feb 07, 2023
BUY
$252.44 - $306.72 $385,223 - $468,054
1,526 Added 3.72%
42,551 $11.8 Million
Q3 2022

Nov 14, 2022
SELL
$194.69 - $268.46 $932,175 - $1.29 Million
-4,788 Reduced 10.45%
41,025 $11 Million
Q2 2022

Aug 12, 2022
SELL
$187.54 - $223.02 $53,073 - $63,114
-283 Reduced 0.61%
45,813 $9.34 Million
Q1 2022

May 16, 2022
BUY
$193.77 - $244.14 $21,702 - $27,343
112 Added 0.24%
46,096 $9.71 Million
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $732,890 - $941,871
-3,273 Reduced 6.64%
45,984 $11 Million
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $3.2 Million - $4.18 Million
11,320 Added 29.84%
49,257 $13.9 Million
Q2 2021

Aug 13, 2021
SELL
$259.0 - $414.71 $889,147 - $1.42 Million
-3,433 Reduced 8.3%
37,937 $13.1 Million
Q1 2021

May 14, 2021
BUY
$242.95 - $284.63 $375,357 - $439,753
1,545 Added 3.88%
41,370 $11.6 Million
Q4 2020

Feb 12, 2021
BUY
$236.26 - $355.63 $647,116 - $974,070
2,739 Added 7.39%
39,825 $9.75 Million
Q3 2020

Nov 09, 2020
BUY
$264.77 - $305.71 $1.09 Million - $1.26 Million
4,110 Added 12.46%
37,086 $10.5 Million
Q2 2020

Aug 13, 2020
BUY
$258.66 - $342.55 $457,310 - $605,628
1,768 Added 5.67%
32,976 $8.82 Million
Q1 2020

May 14, 2020
SELL
$268.85 - $341.04 $629,646 - $798,715
-2,342 Reduced 6.98%
31,208 $9.87 Million
Q4 2019

Feb 14, 2020
SELL
$220.06 - $304.07 $84,282 - $116,458
-383 Reduced 1.13%
33,550 $9.96 Million
Q3 2019

Nov 13, 2019
SELL
$217.44 - $243.88 $5,218 - $5,853
-24 Reduced 0.07%
33,933 $7.9 Million
Q2 2019

Aug 09, 2019
SELL
$219.29 - $241.72 $2.46 Million - $2.71 Million
-11,202 Reduced 24.81%
33,957 $7.94 Million
Q1 2019

May 08, 2019
SELL
$216.71 - $338.96 $5,417 - $8,474
-25 Reduced 0.06%
45,159 $10.7 Million
Q4 2018

Feb 07, 2019
BUY
$278.5 - $352.75 $701,263 - $888,224
2,518 Added 5.9%
45,184 $13.6 Million
Q3 2018

Nov 14, 2018
SELL
$293.51 - $383.83 $79,834 - $104,401
-272 Reduced 0.63%
42,666 $15.1 Million
Q2 2018

Aug 14, 2018
SELL
$257.52 - $306.91 $1.29 Million - $1.54 Million
-5,013 Reduced 10.45%
42,938 $12.5 Million
Q1 2018

May 15, 2018
SELL
$260.13 - $367.91 $762,441 - $1.08 Million
-2,931 Reduced 5.76%
47,951 $13.1 Million
Q4 2017

Feb 14, 2018
BUY
$307.64 - $344.58 $1.69 Million - $1.9 Million
5,501 Added 12.12%
50,882 $16.2 Million
Q3 2017

Nov 14, 2017
BUY
$281.15 - $329.69 $6.14 Million - $7.2 Million
21,847 Added 92.83%
45,381 $14.2 Million
Q2 2017

Aug 14, 2017
BUY
N/A
23,534
23,534 $6.39 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email